Rising Demand for Non-Invasive Imaging Solutions Drives the Mobile Gamma Cameras Market to New Heights

MARKET OVERVIEW:

The global mobile gamma cameras market is witnessing steady growth, driven by increasing chronic disease prevalence, such as cancer and cardiovascular diseases. These portable imaging devices are gaining traction in both outpatient and emergency healthcare settings due to their flexibility and enhanced diagnostic capabilities. With advancements in imaging technology, including high-resolution detectors and software integration, the market is expected to reach USD 79.2 million by 2033, growing at a CAGR of 3.39% from 2025 to 2033.

STUDY ASSUMPTION YEARS:

• BASE YEAR: 2024
• HISTORICAL YEAR: 2019-2024
• FORECAST YEAR: 2025-2033

MOBILE GAMMA CAMERAS MARKET KEY TAKEAWAYS:

• Market size valued at USD 57.8 million in 2024, expected to reach USD 79.2 million by 2033.
• The market is growing at a CAGR of 3.39% from 2025-2033.
• North America holds over 35% of the market share.
• Rising demand for portable diagnostic tools in oncology and cardiology.
• Increasing adoption due to technological advancements, including solid-state detectors and software integration.
• Surge in chronic diseases such as cancer, contributing to higher demand.
• High prevalence of cardiovascular disorders and aging populations boosts market growth.

MARKET GROWTH FACTORS:

Technological Advancements
Mobile gamma cameras are undergoing a revolution in diagnostic capabilities due to the use of innovative solid-state detectors coupled with high-energy collimators. This innovation provides better image resolution, a quicker turnaround, and sturdier portability. As the imaging technology becomes more advanced, mobile gamma cameras develop into more accurate diagnostic tools in oncology and cardiology. Furthermore, the proliferation of artificial intelligence and machine learning further refine diagnosis by allowing real-time image evaluation to support better patient outcomes. These tools will be used by healthcare providers to enhance their operational efficiency, ensuring that advanced imaging systems become more widely available across different settings.

Shift Toward Portable and Point-of-Care Solutions
The growing trend toward decentralization of healthcare services is altering the landscape for mobile and point-of-care diagnostic solutions. Mobile gamma cameras offer new operational flexibility compared to traditional stationary systems. They make remote imaging possible in outpatient clinics, emergency rooms, and the patient's side, thus aiding in timely diagnoses. This tendency is most beneficial for regions where healthcare infrastructure is sparse, or patients with impaired mobility. To the extent possible, such mobile solutions can help economize costs in healthcare by avoiding the need for extensive set ups of imaging suites. The demand for cost-effective, flexible diagnostic tools has fueled the global adoption of mobile gamma cameras.

Growing Prevalence of Chronic Diseases
The increasing incidents of chronic diseases such as cancers and cardiovascular diseases largely drive the mobile gamma cameras market. An increase in demand for an early diagnosis and effective treatment means that portable gamma cameras are indispensable in bringing about rapid, timely, and accurate imaging in different healthcare settings. Giving some assurance to global healthcare systems to be able to affect timely diagnoses is the capacity of mobile gamma cameras to expedite the whole diagnostic effort in such situations, more so for older patients who carry with them a higher burden of risk for chronic disease development. Additionally, with heightened interest in preventive healthcare and early diagnosis, these imaging devices are even more in demand.

MARKET SEGMENTATION:

• By Product:
  • Single-head Mobile Gamma Cameras: These cameras offer basic functionality with a single detector head, suitable for general imaging.
  • Dual-head Mobile Gamma Cameras: Equipped with two detector heads, providing enhanced imaging capabilities and faster diagnostic results.
  • Triple-head Mobile Gamma Cameras: These cameras feature three detector heads, offering the highest resolution and speed for advanced diagnostic applications.
• By Application:
  • Oncology: Utilized for detecting and monitoring cancer through imaging of radioactive tracers.
  • Cardiology: Used for heart-related imaging, such as identifying blockages or abnormal blood flow.
• By End User:
  • Hospitals: Major institutions for advanced diagnostic imaging.
  • Clinics: Outpatient settings that require portable imaging solutions.
  • Research Institutes: Used for clinical trials and studies on imaging technologies and treatments.
• Breakup by Region:
  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

REGIONAL INSIGHTS:

North America is expected to register dominance in the mobile gamma cameras market, with more than 35% market share in 2024. Key factors driving market growth include a favorable healthcare infrastructure, increasing demand for portable imaging solutions, and growing chronic disease incidences, including cancer and cardiovascular conditions. Furthermore, supportive government initiatives coupled with healthcare expenditure further nurture the growth of the mobile gamma camera market in North America.

RECENT DEVELOPMENTS & NEWS:

With tech advancements comes a surge in demand for mobile gamma cameras. Companies are participating in the enhancing of image quality and diagnostic accuracy through the application of solid-state detectors and artificial intelligence. Further, device miniaturization has contributed to the portability and cost-effectiveness of these mobile gamma cameras and augmented their availability for many healthcare settings. Innovations that contribute to mitigating diagnostic errors and enhance patient outcomes play an important role in fuelling market growth.

KEY PLAYERS:

• CMR Naviscan Corporation
• Crystal Photonics GmbH
• DDD-Diagnostic A/S
• Digirad Corporation
• Dilon Medical Technologies Inc.
• GAEDE Medizinsysteme GmbH
• Mediso Ltd.
• MiE GmbH
• Oncovision Inc.
• Siemens AG
• Spectrum Dynamics Medical (Biosensors International Group Ltd.)

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, considerations studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.